Hancock Jaffe Laboratories, Inc.

Home » Hancock Jaffe Laboratories, Inc.

IPO

Hancock Jaffe Laboratories, Inc.

We are a development stage medical device company developing biologic-based solutions that are designed to be life-enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease, or ESRD.

Symbol

HJLI

Price Range
$6.00 - $8.00

Final Shares
1,142,000

Anticipated Date
TBD

Underwriters
Network 1 Financial

To view the prospectus for Hancock Jaffe Laboratories, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253